David Ross
21Patents
3h-index
26Co-inventors
63Inventor score
Filing activity: May 24, 1999 → Aug 17, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6156744A | DT-diaphorase directed anti-tumor agents | Chemistry; Metallurgy | 6 | Expired |
| US9353121B2 | Anti-cancer compounds targeting Ral GTPases and methods of using the same | Human Necessities | 6 | Active |
| US9913903B2 | Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM | Emerging Cross-Sectional Technologies | 4 | Active |
| US10202397B2 | Anti-cancer compounds targeting Ral GTPases and methods of using the same | Human Necessities | 2 | Active |
| US10660956B2 | Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM | Emerging Cross-Sectional Technologies | 1 | Active |
| USRE49129E1 | Method of treatment of hypoxia inducible factor (HIF)-related conditions | General | 1 | Active |
| US8551964B2 | Hsp90 inhibitors with modified toxicity | Chemistry; Metallurgy | 1 | Active |
| US7608611B2 | Hsp90 inhibitors, methods of making and uses therefor | Chemistry; Metallurgy | 1 | Expired |
| US10570194B2 | Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM) | Emerging Cross-Sectional Technologies | 1 | Active |
| US10676480B2 | Anti-cancer compounds targeting Ral GTPases and methods of using the same | Human Necessities | 1 | Active |
| US11208471B2 | Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM) | Emerging Cross-Sectional Technologies | 0 | Active |
| US10214487B2 | Indole derivatives and methods of using the same | Human Necessities | 0 | Active |
| USRE50230E1 | Method of treatment of hypoxia inducible factor (HIF)-related conditions | General | 0 | Active |
| US10689392B2 | Anti-cancer compounds targeting ral GTPases and methods of using the same | Human Necessities | 0 | Active |
| US11756068B2 | Systems and methods for providing interaction with electronic billboards | Physics | 0 | Active |
| USRE48557E1 | Anti-cancer compounds targeting Ral GTPases and methods of using the same | General | 0 | Active |
| US12280110B2 | Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM | Emerging Cross-Sectional Technologies | 0 | Active |
| US9687530B2 | Method of treatment of Hypoxia Inducible Factor (HIF)-related conditions | Human Necessities | 0 | Active |
| US11472812B2 | Anti-cancer compounds targeting Ral GTPases and methods of using the same | Human Necessities | 0 | Active |
| US11964985B2 | Anti-cancer compounds targeting Ral GTPases and methods of using the same | Human Necessities | 0 | Active |
| US9603829B2 | HSP90 inhibitors with modified toxicity | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.